Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Feb 11;2(2):CD011349.
doi: 10.1002/14651858.CD011349.pub2.

Conjunctival autograft for pterygium

Elizabeth Clearfield  1 , Valliammai Muthappan, Xue Wang, Irene C Kuo
Affiliations
Meta-Analysis

Conjunctival autograft for pterygium

Elizabeth Clearfield et al. Cochrane Database Syst Rev. .

Abstract

Background: A pterygium is a fleshy, wing-shaped growth from the conjunctiva, crossing over the limbus onto the cornea. Prevalence ranges widely around the world. Evidence suggests that ultraviolet light is a major contributor in the formation of pterygia. Pterygia impair vision, limit eye movements, and can cause eye irritation, foreign body sensation, and dryness. In some susceptible patients, the pterygium can grow over the entire corneal surface, blocking the visual axis.Surgery is the only effective treatment for pterygium, though recurrences are common. With simple excision techniques (that is, excising the pterygium and leaving bare sclera), the risk of recurrence has been reported to be upwards of 80%. Pterygium excision combined with a tissue graft has a lower risk of recurrence. In conjunctival autograft surgery, conjunctival tissue from another part of the person's eye along with limbal tissue is resected in one piece and used to cover the area from which the pterygium was excised. Another type of tissue graft surgery for pterygium is amniotic membrane graft, whereby a piece of donor amniotic membrane is fixed to the remaining limbus and bare sclera area after the pterygium has been excised.

Objectives: The objective of this review was to assess the safety and effectiveness of conjunctival autograft (with or without adjunctive therapy) compared with amniotic membrane graft (with or without adjunctive therapy) for pterygium. We also planned to determine whether use of MMC yielded better surgical results and to assess the direct and indirect comparative costs of these procedures.

Search methods: We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register) (Issue 10, 2015), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to November 2015), EMBASE (January 1980 to November 2015), PubMed (1948 to November 2015), Latin American and Caribbean Health Sciences Literature Database (LILACS) (1982 to November 2015), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com) (last searched 21 November 2014), ClinicalTrials.gov (www.clinicaltrials.gov) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic search for trials. We last searched the electronic databases on 23 November 2015.

Selection criteria: We included in this review randomized controlled trials that had compared conjunctival autograft surgery (with or without adjunctive therapy) with amniotic membrane graft surgery (with or without adjunctive therapy) in people with primary or recurrent pterygium.

Data collection and analysis: Two review authors independently screened search results and assessed full-text reports from among the potentially eligible trials. Two review authors independently extracted data from the included trials and assessed the trial characteristics and risk of bias. The primary outcome was the risk of recurrence of pterygium at 3 months and 6 months after surgery. We combined results from individual studies in meta-analyses using random-effects models. Risk of recurrence of pterygium was reported using risk ratios to compare conjunctival autograft with amniotic membrane transplant.

Main results: We identified 20 studies that had analyzed a total of 1947 eyes of 1866 participants (individual studies ranged from 8 to 346 participants who were randomized). The studies were conducted in eight different countries: one in Brazil, three in China, three in Cuba, one in Egypt, two in Iran, two in Thailand, seven in Turkey, and one in Venezuela. Overall risk of bias was unclear, as many studies did not provide information on randomization methods or masking to prevent performance and detection bias.The risk ratio for recurrence of pterygium using conjunctival autograft versus amniotic membrane transplant was 0.87 (95% confidence interval (CI) 0.43 to 1.77) and 0.53 (95% CI 0.33 to 0.85) at 3 months and 6 months, respectively. These estimates include participants with primary and recurrent pterygia. We performed a subgroup analysis to compare participants with primary pterygia with participants with recurrent pterygia. For participants with primary pterygia, the risk ratio was 0.92 (95% CI 0.37 to 2.30) and 0.58 (95% CI 0.27 to 1.27) at 3 months and 6 months, respectively. We were only able to estimate the recurrence of pterygia at 6 months for participants with recurrent pterygia, and the risk ratio comparing conjunctival autograft with amniotic membrane transplant was 0.45 (95% CI 0.21 to 0.99). One included study was a doctoral thesis and did not use allocation concealment. When this study was excluded in a sensitivity analysis, the risk ratio for pterygium recurrence at 6 months' follow-up was 0.43 (95% CI 0.30 to 0.62) for participants with primary and recurrent pterygium. One of the secondary outcomes, the proportion of participants with clinical improvement, was analyzed in only one study. This study reported clinical outcome as the risk of non-recurrence, which was seen in 93.8% of participants in the conjunctival limbal autograft group and 93.3% in the amniotic membrane transplant group at 3 months after surgery.We did not analyze data on the need for repeat surgery, vision-related quality of life, and direct and indirect costs of surgery due to an insufficient number of studies reporting these outcomes.Thirteen studies reported adverse events associated with conjunctival autograft surgery and amniotic membrane transplant surgery. Adverse events that occurred in more than one study were granuloma and pyogenic granuloma and increased intraocular pressure. None of the included studies reported that participants had developed induced astigmatism.

Authors' conclusions: In association with pterygium excision, conjunctival autograft is associated with a lower risk of recurrence at six months' after surgery than amniotic membrane transplant. Participants with recurrent pterygia in particular have a lower risk of recurrence when they receive conjunctival autograft surgery compared with amniotic membrane transplant. There are few studies comparing the two techniques with respect to visual acuity outcomes, and we identified no studies that reported on vision-related quality of life or direct or indirect costs. Comparison of these two procedures in such outcome measures bears further investigation. There were an insufficient number of studies that used adjunctive mitomycin C to estimate the effects on pterygium recurrence following conjunctival autograft or amniotic membrane transplant.

PubMed Disclaimer

Conflict of interest statement

DECLARATIONS OF INTEREST EC: No conflict of interest or financial interest. VM: No conflict of interest or financial interest. XW: No conflict of interest or financial interest. ICK: No conflict of interest or financial interest.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgments about each risk of bias item for each included study.
4
4
Forest plot of comparison: 1 Conjunctival autograft (CAG) versus amniotic membrane transplant (AMT), outcome: 1.1 Recurrence of pterygium at 3 months.
5
5
Forest plot of comparison: 1 Conjunctival autograft (CAG) versus amniotic membrane transplant (AMT), outcome: 1.2 Recurrence of pterygium at 6 months.
6
6
Forest plot of comparison: 1 Conjunctival autograft (CAG) versus amniotic membrane transplant (AMT), outcome: 1.3 Adverse events.
1.1
1.1. Analysis
Comparison 1 Conjunctival autograft (CAG) versus amniotic membrane transplant (AMT), Outcome 1 Recurrence of pterygium at 3 months.
1.2
1.2. Analysis
Comparison 1 Conjunctival autograft (CAG) versus amniotic membrane transplant (AMT), Outcome 2 Recurrence of pterygium at 6 months.
1.3
1.3. Analysis
Comparison 1 Conjunctival autograft (CAG) versus amniotic membrane transplant (AMT), Outcome 3 Adverse events.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD011349

References

References to studies included in this review

Aragonés Cruz 2008 {published data only}
    1. Aragonés Cruz B, Alemañy Martorell J. Comparative study of the use of mitomycin C in recurrent pterygium [Estudio comparativo del uso de mitomicina C en el pterigium recidivante]. Revista Cubana de Oftalmología 2008;21(2):1‐11.
Besharati 2008 {published data only}
    1. Besharati MR, Miratashi SA, Ahmadi AB. Pterygium surgery: amniotic membrane or conjunctival autograft transplantation. International Journal of Ophthalmology 2008;1(4):362‐6.
Chen 2009 {published data only}
    1. Chen L, Mu L, Li MX. Clinical observation of three different operation methods for recurrent pterygium. International Journal of Ophthalmology 2009;9(11):2211‐3.
Chen 2012 {published data only}
    1. Chen LR, Yao JP, Zhu Y, Zhang YZ, Zhou Y, Gao B. Comparative analysis of surgical excision combined with limbal stem cell transplantation and amniotic membrane transplantation for the treatment of pterygium. International Eye Science 2012;12(10):2006‐8.
Fernández García 2012 {published data only}
    1. Fernández García K, Gómez Castillo Z, Castillo Pérez A, Pérez Parra Z, Jareño Ochoa M, Perea Ruiz CA. Use of conjunctival autograft and amniotic membrane in primary pterygium surgery [Autoinjerto conjuntival y membrana amnióticaen la cirugía del pterigión primario]. Revista Cubana de Oftalmología 2012;25(2):212‐7.
Katircioglu 2014 {published data only}
    1. Katircioglu YA, Altiparmak U, Goktas SE, Cakir B, Singar E, Ornek F. Comparison of two techniques for the treatment of recurrent pterygium: amniotic membrane vs conjunctival autograft combined with mitomycin C. Seminars in Ophthalmology 2015;30(5‐6):321‐7. - PubMed
Keklikci 2007 {published data only}
    1. Keklikci U, Celik Y, Cakmak SS, Unlu MK, Bilek B. Conjunctival‐limbal autograft, amniotic membrane transplantation, and intraoperative mitomycin C for primary pterygium. Annals of Ophthalmology 2007;39(4):296‐301. - PubMed
Kheirkhah 2011 {published and unpublished data}
    1. Kheirkhah A, Nazari R, Nikdel M, Ghassemi H, Hashemi H, Behrouz MJ. Postoperative conjunctival inflammation after pterygium surgery with amniotic membrane transplantation versus conjunctival autograft. American Journal of Ophthalmology 2011;152(5):733‐8. - PubMed
Küçükerdönmez 2007 {published data only}
    1. Küçükerdönmez C, Akova YA, Altinörs DD. Vascularization is more delayed in amniotic membrane graft than conjunctival autograft after pterygium excision. American Journal of Ophthalmology 2007;143(2):245‐9. - PubMed
Küçükerdönmez 2007a {published data only}
    1. Küçükerdönmez C, Akova YA, Altinörs DD. Comparison of conjunctival autograft with amniotic membrane transplantation for pterygium surgery. Cornea 2007;26(4):407‐13. - PubMed
    1. Küçükerdönmez C, Dursin D, Akova YA. Comparison of conjunctival autograft with amniotic membrane transplantation for pterygium surgery: surgical and cosmetic outcome. American Academy of Ophthalmology. 2004; Vol. 179. - PubMed
Liang 2012 {published data only}
    1. Liang W, Li R, Deng X. Comparison of the efficacy of pterygium resection combined with conjunctival autograft versus pterygium resection combined with amniotic membrane transplantation. Eye Science 2012;27(2):102‐5. - PubMed
Luanratanakorn 2006 {published data only}
    1. Luanratanakorn P, Ratanapakorn T, Suwan‐Apichon O, Chuck RS. Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision. British Journal of Ophthalmology 2006;90(12):1476‐80. - PMC - PubMed
Ozer 2009 {published data only}
    1. Ozer A, Yildirim N, Erol N, Yurdakul S. Long‐term results of bare sclera, limbal‐conjunctival autograft and amniotic membrane graft techniques in primary pterygium excisions. Ophthalmologica 2009;223(4):269‐73. - PubMed
Paes 2010 {published data only}
    1. Fernandes LM, Paes JP, Morais BBO, Costa CMG, Oliveira EM, Felix FS, et al. Surgical treatment of primary pterygium: comparison between techniques of autologous conjunctive transplant and transplantation of amniotic membrane. Investigative Ophthalmology and Visual Science 2007; Vol. 48, issue 13:ARVO E‐Abstract 5296.
    1. Pereira Paes J. Surgical Treatment of the Primary Pterygium: Comparison Between Rotation of Conjunctival Flap and Amniotic Membrane Transplant [Tratamento Cirurgico do Pterigio Primario: Comparação Entre as Tecnicas de Rotação de Retalho Conjuntival e Transplante de Membrana Amniotica] [Doctoral dissertation]. Universidade Estadual de Campinas. Faculdade de Ciências Médicas, 2010.
Pérez Parra 2008 {published data only}
    1. Pérez Parra Z, Castillo Pérez ADLC, Escalona Leyva E, López Hernández S, Márquez Villalón S. Conjunctival autograft versus amniotic membrane graft in primary pterygium surgery [Autoinjerto conjuntival versus injerto de membrana amniótica en la cirugía del pterigión primario]. Revista Cubana de Oftalmología 2008;21(1):0.
Perry 2000 {published data only}
    1. Perry HD, Kanellopoulos AJ, Donnenfeld ED, Doshi SJ. Comparison of amniotic membrane transplantation (AMT) to conjunctival autograft (CAT) in the surgical management of pterygia. American Academy of Ophthalmology. 2000:225.
Salman 2011 {published data only}
    1. Salman AG, Mansour DE. The recurrence of pterygium after different modalities of surgical treatment. Saudi Journal of Ophthalmology 2011;25(4):411‐5. - PMC - PubMed
Stangogiannis‐Druya 2004 {published data only}
    1. Stangogiannis‐Druya E, Martínez M, Paz EL, Márquez K, Stangogiannis‐Druya C. Amniotic membrane graft or conjunctival autograft in recurrent nasal pterygium Hospital Unversitario de Caracas January‐June 2004 [Transplante de membrana amniótica o auto injerto conjuntival en pterigión nasal recidivantes Hospital universitario de Caracas enero‐junio 2004]. Revista Oftalmológica Venezolana 2004;60(4):181‐7.
Tananuvat 2004 {published data only}
    1. Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea 2004;23(5):458‐63. - PubMed
Toker 2016 {published data only}
    1. Toker E, Eraslan M. Recurrence after primary pterygium excision: amniotic membrane transplantation with fibrin glue versus conjunctival autograft with fibrin glue. Current Eye Research 2016;41(1):1‐8. - PubMed

References to studies excluded from this review

Katircioglu 2007 {published data only}
    1. Katircioglu YA, Altiparmak UE, Duman S. Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C. Orbit 2007;26(1):5‐13. - PubMed
Kim 2008 {published data only}
    1. Kim HJ, Lee SY. The comparative study of clinical results in surgically treated pterygium patients with amniotic membrane transplantation versus limbal autograft. Investigative Ophthalmology and Visual Science 2008; Vol. 49, issue 13:ARVO E‐abstract 6031.
Li 2014 {published data only}
    1. Li T, Chen SX, Xia XG, Yin Z, Huang MZ, Guo PY. Pterygium conjunctive reverse transplantation combined with amniotic membrane transplantation on recurrent pterygium. International Eye Science 2014;14(9):1715‐6.
Lin 2009 {published data only}
    1. Lin XS, Song YP. Comparison between amniotic membrane transplantation and conjunctival autograft for treating pterygium. International Journal of Ophthalmology 2009;9(7):1367‐8.
Liu 2014 {published data only}
    1. Liu J, Wang Y, Yuan JM. Different surgical methods on the tear film stability in treating pterygium patients. International Eye Science 2015;15(3):558‐61.
Nava‐Castaneda 2007 {published data only}
    1. Nava‐Castaneda A, Garnica‐Hayashi L, Jaimes M, Garfias Y. Comparative study of concentration of Muc5ac and Muc2 mucins in tear film in surgical treated pterygiums with amniotic membrane transplantation vs conjunctival autograft. Investigative Ophthalmology and Visual Science 2007;48(13):ARVO E‐Abstract 5290.
Ozkurt 2009 {published data only}
    1. Ozkurt YB, Kocams O, Comez AT, Uslu B, Dogan OK. Treatment of primary pterygium. Optometry and Vision Science 2009;86(10):1178‐81. - PubMed
Paris 2008 {published data only}
    1. Paris FDS, Farias CC, Melo GB, Dos Santos MS, Batista JLA, Comes JAP. Postoperative subconjunctival corticosteroid injection to prevent pterygium recurrence. Cornea 2008;27(4):406‐10. - PubMed
Pei 2011 {published data only}
    1. Pei Y, Huang Y, Xiao F, Cheng WW, Yang J. Comparison of the effects of two kinds of surgery in pterygium. International Journal of Ophthalmology 2011;11(10):1835‐7.
Xia 2008 {published data only}
    1. Xia ZX, Lan YQ, Wang M, Xiao JH, Guo H, Hu YK. Analysis of efficacy of three different operation modes for preventing recurrence of pterygium. International Journal of Ophthalmology 2008;8(8):1623‐5.
Yan 2010 {published data only}
    1. Yan XY, Chen HM, Tang ZJ. The recurrent rate of different surgical procedures for pterygium after one year. International Journal of Ophthalmology 2010;10(7):1423‐4.
Zhang 2014 {published data only}
    1. Zhang WW, Xie P. Comparation on effect of two kinds operation in treatment of recurrent pterygium with symblepharon. International Eye Science 2014;14(12):2286‐8.

References to studies awaiting assessment

CTRI/2015/07/005960 {unpublished data only}
    1. CTRI/2015/07/005960. Comparative outcome of conjunctival autograft and amniotic membrane transplantation following double pterygium excision in the same eye. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10669.

Additional references

Barraquer 1965
    1. Barraquer J. The Cornea World Congress. Washington: Butterworths, 1965.
Bultmann 1999
    1. Bultmann S, You L, Spandau U. Amniotic membrane down‐regulates chemokine expression in human keratocytes. Investigative Ophthalmology and Visual Science 1999;40:S578.
Chen 1995
    1. Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. American Journal of Ophthalmology 1995;120(2):151‐60. - PubMed
Coroneo 1999
    1. Coroneo MT, Girolamo N, Wakefield D. The pathogenesis of pterygia. Current Opinion in Ophthalmology 1999;10(4):282‐8. - PubMed
D'Ombrain 1948
    1. D'Ombrain A. The surgical treatment of pterygium. British Journal of Ophthalmology 1948;32(2):65‐71. - PMC - PubMed
Droutsas 2010
    1. Droutsas K, Sekundo W. Epidemiology of pterygium. A review [Epidemiologie des pterygiums. Eine ubersicht]. Der Ophthalmologe 2010;107(6):511‐6. - PubMed
Guyatt 2011
    1. Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology 2011;64(4):380‐2. - PubMed
Hao 2000
    1. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000;19(3):348‐52. - PubMed
Higgins 2011a
    1. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins 2011b
    1. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hill 1989
    1. Hill JC, Maske R. Pathogenesis of pterygium. Eye 1989;3(Pt 2):218‐26. - PubMed
Karai 1984
    1. Karai I, Horiguchi S. Pterygium in welders. British Journal of Ophthalmology 1984;68(5):347‐9. - PMC - PubMed
Kenyon 1985
    1. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985;92(11):1461‐70. - PubMed
Kim 1995
    1. Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995;14(5):473‐84. - PubMed
Kirwan 2003
    1. Kirwan JF, Constable PH, Murdoch IE, Khaw PT. Beta irradiation: new uses for an old treatment: a review. Eye 2003;17(2):207‐15. - PubMed
Klein 1876
    1. Klein S. [Zur operation des pterygium und zur transplantation von schleimhaut]. Allgemeine Wien Medizinischen Zeitung 1876;21:19.
Kobayashi 1999
    1. Kobayashi A, Inana G, Meller D. Differential gene expression by human cultured umbilical vein endothelial cells on amniotic membrane. 4th Ocular Surface and Tear Conference, Miami, FL, USA. 14 May 1999.
Kwok 1994
    1. Kwok LS, Coroneo MT. A model for pterygium formation. Cornea 1994;13(3):219‐24. - PubMed
Li 2012
    1. Li M, Zhu M, Yongfu Y, Gong L, Zhao N, Robitaille MJ. Comparison of conjunctival autograft transplantation and amniotic membrane transplantation for pterygium: a meta‐analysis. Cornea 2012;250(3):375‐81. - PubMed
Liu 2013
    1. Liu L, Wu J, Geng J, Yuan Z, Huang D. Geographical prevalence and risk factors for pterygium: a systematic review and meta‐analysis. BMJ Open 2013;3(11):1‐8. - PMC - PubMed
Prabhasawat 1997
    1. Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 1997;104(6):974‐85. - PubMed
Raj 2010
    1. Raj AKS. Clinical study to compare the incidence of recurrence after pterygium excision with bare sclera technique without intraoperative mitomycin C, with intraoperative mitomycin C application and conjunctival limbal autograft. Dissertation submitted to the Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore 2010.
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Shimazaki 1998
    1. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. British Journal of Ophthalmology 1998;82(3):235‐40. - PMC - PubMed
Singh 2005
    1. Singh G. Pterygium and its surgery. In: Smolin G, Foster CS, Azar DT, Dohlman CH editor(s). Smolin and Thoft's The Cornea: Scientific Foundations and Clinical Practice. Lippincott Williams and Wilkins, 2005:1001.
Solomon 1999
    1. Solomon A, Monroy D, Ji Z. Suppression of epithelial expression of IL‐1‐beta by the amniotic membrane. 4th Ocular Surface and Tear Conference, Miami, FL, USA. 14 May 1999.
Tseng 1999
    1. Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor‐beta isoforms, TGF‐beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. Journal of Cellular Physiology 1999;179(3):325‐35. - PubMed

Publication types

LinkOut - more resources